The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...

The Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for ...

Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...

HNIs’ holdings in NSE-listed stocks surged 22.55% QoQ to a record Rs 9.92 lakh crore by June-end, adding Rs 1.83 lakh crore in three months...

Entero Healthcare Solutions shares rose sharply after Prashant Jain-owned 3P Investment Managers acquired a 2.5% stake in the company throu...

Aurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...

Urban Company shares rallied on Monday, after a bullish brokerage call and a legal development involving Kent RO. Kent RO has agreed to rem...

Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

Horizon Industrial Parks made a muted stock market debut on Monday, with shares listing nearly flat at Rs 59.65 on the BSE against an IPO p...

US tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...

India's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...

Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...

Strides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...

Pharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...

Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...

In September 2026, several prominent companies are set to implement significant workforce reductions. Both Oracle and Pinterest are letting...